tradingkey.logo
搜索

Vivos Therapeutics Inc

VVOS
添加自选
0.410USD
+0.004+1.03%
收盘 07-31 16:00美东报价延迟15分钟
3.81M总市值
亏损市盈率 TTM

关于 Vivos Therapeutics Inc 公司

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Inc简介

公司代码VVOS
公司名称Vivos Therapeutics Inc
上市日期Dec 11, 2020
CEOHuntsman (R. Kirk)
员工数量109
证券类型Ordinary Share
年结日Dec 11
公司地址7921 Southpark Plaza,
城市LITTLETON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编80120
电话18669084867
网址https://vivos.com/
公司代码VVOS
上市日期Dec 11, 2020
CEOHuntsman (R. Kirk)

Vivos Therapeutics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

常见问题

Vivos Therapeutics Inc的前五大股东是谁?

Vivos Therapeutics Inc 的前五大股东如下:Mr. Bradford K. (Brad) Amman

有多少机构持有Vivos Therapeutics Inc(VVOS)的股份?

截至2026Q1,共有50家机构持有Vivos Therapeutics Inc的股份,合计持有的股份价值约为1.10M,占公司总股份的8.12%。与2025Q4相比,机构持股有所增加,增幅为-71775.00。

哪个业务部门对Vivos Therapeutics Inc的收入贡献最大?

在2026Q1,Sleep testing services业务部门对Vivos Therapeutics Inc的收入贡献最大,创收2.56M,占总收入的37.74%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有